19-44708169-G-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong

The NM_001039213.4(CEACAM16):​c.1249G>C​(p.Val417Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000315 in 1,576,434 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V417M) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00032 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00032 ( 0 hom. )

Consequence

CEACAM16
NM_001039213.4 missense

Scores

1
1
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.643

Publications

2 publications found
Variant links:
Genes affected
CEACAM16 (HGNC:31948): (CEA cell adhesion molecule 16, tectorial membrane component) The protein encoded by this gene is a secreted glycoprotein that in mouse interacts with tectorial membrane proteins in the inner ear. The encoded adhesion protein is found in cochlear outer hair cells and appears to be important for proper hearing over an extended frequency range. Defects in this gene likely are a cause of non-syndromic autosomal dominant hearing loss. [provided by RefSeq, May 2012]
CEACAM16-AS1 (HGNC:55317): (CEACAM16, CEACAM19 and PVR antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0062960684).
BP6
Variant 19-44708169-G-C is Benign according to our data. Variant chr19-44708169-G-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 227240.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CEACAM16NM_001039213.4 linkc.1249G>C p.Val417Leu missense_variant Exon 6 of 7 ENST00000587331.7 NP_001034302.2
CEACAM16XM_017026795.2 linkc.1249G>C p.Val417Leu missense_variant Exon 5 of 5 XP_016882284.1
CEACAM16-AS1NR_186815.1 linkn.348-8992C>G intron_variant Intron 1 of 1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CEACAM16ENST00000587331.7 linkc.1249G>C p.Val417Leu missense_variant Exon 6 of 7 1 NM_001039213.4 ENSP00000466561.1

Frequencies

GnomAD3 genomes
AF:
0.000315
AC:
48
AN:
152260
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.0127
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000605
AC:
134
AN:
221314
AF XY:
0.000558
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000631
Gnomad ASJ exome
AF:
0.0120
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000163
Gnomad OTH exome
AF:
0.000541
GnomAD4 exome
AF:
0.000315
AC:
449
AN:
1424174
Hom.:
0
Cov.:
34
AF XY:
0.000321
AC XY:
225
AN XY:
701314
show subpopulations
African (AFR)
AF:
0.0000306
AC:
1
AN:
32722
American (AMR)
AF:
0.0000944
AC:
4
AN:
42370
Ashkenazi Jewish (ASJ)
AF:
0.0129
AC:
330
AN:
25534
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38194
South Asian (SAS)
AF:
0.00
AC:
0
AN:
83120
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52052
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5648
European-Non Finnish (NFE)
AF:
0.0000553
AC:
60
AN:
1085888
Other (OTH)
AF:
0.000921
AC:
54
AN:
58646
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
28
56
84
112
140
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000315
AC:
48
AN:
152260
Hom.:
1
Cov.:
33
AF XY:
0.000282
AC XY:
21
AN XY:
74394
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41474
American (AMR)
AF:
0.00
AC:
0
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.0127
AC:
44
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5198
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68040
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
4
7
11
14
18
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00108
Hom.:
0
Bravo
AF:
0.000416
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00106
AC:
9
ExAC
AF:
0.000496
AC:
60

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Sep 27, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Oct 05, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
Jan 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Val417Leu in exon 6 of CEACAM16: This variant is not expected to have clinica l significance due to a lack of conservation across species, including mammals. Of note, 9 mammals have a leucine (Leu) at this position despite high nearby ami no acid conservation. In addition, computational prediction tools do not suggest a high likelihood of impact to the protein. It has been identified in 0.1% (45/ 34408) of European chromosomes by the Exome Aggregation Consortium (ExAC, http:/ /exac.broadinstitute.org; dbSNP rs199597608).

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.32
T
BayesDel_noAF
Benign
-0.44
CADD
Benign
18
DANN
Benign
0.96
DEOGEN2
Benign
0.018
T;T
Eigen
Benign
-0.27
Eigen_PC
Benign
-0.12
FATHMM_MKL
Benign
0.64
D
LIST_S2
Benign
0.0
.;T
M_CAP
Benign
0.0067
T
MetaRNN
Benign
0.0063
T;T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
1.8
L;L
PhyloP100
0.64
PrimateAI
Benign
0.48
T
PROVEAN
Benign
0.0
.;N
REVEL
Benign
0.0
Sift
Pathogenic
0.0
.;T
Sift4G
Uncertain
0.050
T;T
Vest4
0.31
ClinPred
0.011
T
GERP RS
2.5
Varity_R
0.053
gMVP
0.52
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs199597608; hg19: chr19-45211441; API